文献速递系统性红斑狼疮

BAFF缺失下仍可发生小鼠系统性红斑狼疮

Development of Murine Systemic Lupus Erythematosus in the Absence of BAFF.
PubMed 文献 · Arthritis Rheumatol · 2019-12-26

研究在NZM2328狼疮倾向小鼠中敲除BAFF并转入人BCL2转基因使B细胞存活不依赖BAFF,结果小鼠仍出现B细胞与浆细胞增多、自身抗体升高、肾炎及严重蛋白尿和死亡,且病程较野生型更快。提示只要B细胞存活被BAFF非依赖途径维持,BAFF对SLE样病变可能并非必需。

要点

  • BAFF缺失时若B细胞存活被BCL2转基因维持,仍可发生SLE样病变
  • NZM.Baff-/-.Bcl2Tg小鼠中位死亡月龄4.5个月,快于野生型7.5个月
  • 重新引入Baff基因可进一步加速病程,中位死亡月龄3个月

核心结论

  • 只要B细胞存活通过BAFF非依赖途径得以维持,BAFF在SLE样病变发展中可能并非必需。
  • 该模型或可解释BAFF拮抗剂治疗人类SLE临床成功有限且多变。
  • NZM.Baff-/-.Bcl2Tg小鼠可作为研究BAFF非依赖型SLE的小鼠模型。

研究设计与样本

  • 将C57BL/6小鼠B细胞表达的人BCL2转基因回交导入BAFF缺陷的NZM2328小鼠,构建NZM.Baff-/-.Bcl2Tg小鼠。
  • 用流式细胞术评估人Bcl-2表达与淋巴细胞表型,用ELISA检测血清学指标。
  • 用免疫荧光和组织学评估肾脏免疫病理,以严重蛋白尿和死亡评估临床疾病。

主要发现

  • 与非转基因NZM.Baff-/-同窝小鼠(n≥7)相比,NZM.Baff-/-.Bcl2Tg小鼠(n≥8)B细胞过表达Bcl-2。
  • NZM.Baff-/-.Bcl2Tg小鼠B细胞和浆细胞百分比与数量、血清IgG自身抗体水平、肾小球IgG和C3沉积及肾小球与肾小管间质炎症严重程度均显著增加,最终出现严重蛋白尿和死亡(均P<0.05)。
  • NZM.Baff-/-.Bcl2Tg小鼠SLE样特征出现较既往NZM2328野生型更快,中位死亡月龄4.5个月对7.5个月。
  • 重新引入Baff基因后病程进一步加速,中位死亡月龄3个月。

临床怎么用

  • 解读BAFF靶向治疗SLE疗效有限时,需考虑B细胞存活可能经BAFF非依赖途径维持。
  • 该小鼠模型可用于研究BAFF非依赖型SLE的发病机制。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether systemic lupus erythematosus (SLE) can develop in the absence of BAFF in an SLE-prone host. METHODS: Starting with C57BL/6 mice that express a human BCL2 transgene (Tg) in their B cells (thereby rendering B cell survival largely independent of BAFF-triggered signals), we introgressed this Tg into NZM 2328 mice genetically deficient in BAFF (NZM.Baff-/- ) to generate NZM.Baff-/- .Bcl2Tg mice. Expression of human Bcl-2 and lymphocyte profiles were assessed by fluorescence-activated cell sorting, and serologic profiles were determined by enzyme-linked immunosorbent assay. Immunofluorescence and histologic analyses were performed to assess renal immunopathologic features in the mice, and clinical disease was assessed according to the outcomes of severe proteinuria and death. RESULTS: In comparison to their non-Tg NZM.Baff-/- littermates (n ≥ 7), NZM.Baff-/- .Bcl2Tg mice (n ≥ 8) overexpressed Bcl-2 in their B cells and developed significantly increased percentages and numbers of B cells and plasma cells, serum levels of IgG autoantibodies, glomerular deposition of IgG and C3, and severity of glomerular and tubulointerstitial inflammation, culminating in severe proteinuria and death (all P < 0.05 versus NZM.Baff-/- littermates). The time course for development of SLE-like features in NZM.Baff-/- .Bcl2Tg mice was more rapid than has been previously observed in NZM 2328 wild-type mice (median age at death 4.5 months versus 7.5 months). NZM.Baff-/- .Bcl2Tg mice remained responsive to BAFF, since reintroduction of the Baff gene into these mice further accelerated the course of disease (median age at death 3 months). CONCLUSION: The role of BAFF in the development of SLE-like disease may be dispensable as long as B cell survival is preserved via a BAFF-independent pathway. This may help explain the limited and variable clinical success with BAFF antagonists in human SLE. Thus, NZM.Baff-/- .Bcl2Tg mice may serve as a powerful murine model for the study of BAFF-independent SLE.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Stohl W, Yu N, Chalmers S, et al. Development of Murine Systemic Lupus Erythematosus in the Absence of BAFF. Arthritis Rheumatol. 2019. PMID: 31493335. doi:10.1002/art.41097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。